In the global race to tame the spread of COVID-19, scientific researchers and pharmaceutical companies first must understand the virus’s protein structure. Doing so requires building detailed 3D models of protein molecules, which until recently has been an intensely time-consuming task. Structura Biotechnology’s groundbreaking software is helping speed things along. The GPU-powered machine learning algorithms Read article >
The post A Binding Decision: Startup Uses Microscopy Breakthrough to Speed Creation of COVID-19 Vaccines appeared first on The Official NVIDIA Blog.
- View Press Release
- Visit NVIDIA Corporation